Ergoteles’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ergoteles’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-991,237	Closed	-$164M	–	1885
2021 Q2	$164M	Buy	991,237 +957,807	+2,865%	+$160M	3.75%	1
2021 Q1	$5.13M	Buy	33,430 +22,930	+218%	+$3.11M	0.16%	162
2020 Q4	$1.32M	Buy	+10,500	New	+$1.17M	0.04%	286

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Ergoteles's PRAH Position: Q3 2021 in Review

Ergoteles sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 991,237 shares — an estimated $164M sold.

Ergoteles first reported a position in PRAH in Q4 2020 and held it in 3 quarters. The position peaked at $164M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Ergoteles reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 991,237 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $164M.
Ergoteles first reported a position in PRA Health Sciences, Inc. in Q4 2020 and held it in 3 quarters.
Ergoteles's PRA Health Sciences, Inc. position peaked at $164M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.